tajdistributors.adm@yahoo.com - GST NO. : 33ACGPF5198L1ZB
14,000.00 / bottle
| Business Type | Exporter, Supplier, Trader |
| Speciality | Medical Oncology |
| Strength | 15 Mg |
| Type | Allopathic |
| Click to view more | |
Product Details
Form
Tablets
Composition
Ponatinib
Storage
Cool & Dry Place
Generic Name
Ponaxem 15
Payment Terms
T/T, Western Union
Iclusig Ponatinib is used to treat certain types of blood cancer (chronic myelogenous leukemia-CML, acute lymphoblastic leukemia-ALL).Iclusig is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy (1).This indication is based upon response rate. There are no trials verifying an improvement in disease-related symptoms or increased survival with Iclusig
Looking for "Ponatinib Tablets" ?
Box
